These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Blockade of substance P (neurokinin 1) receptors enhances extracellular serotonin when combined with a selective serotonin reuptake inhibitor: an in vivo microdialysis study in mice. Guiard BP, Przybylski C, Guilloux JP, Seif I, Froger N, De Felipe C, Hunt SP, Lanfumey L, Gardier AM. J Neurochem; 2004 Apr; 89(1):54-63. PubMed ID: 15030389 [Abstract] [Full Text] [Related]
7. Functional consequences of 5-HT transporter gene disruption on 5-HT(1a) receptor-mediated regulation of dorsal raphe and hippocampal cell activity. Mannoury la Cour C, Boni C, Hanoun N, Lesch KP, Hamon M, Lanfumey L. J Neurosci; 2001 Mar 15; 21(6):2178-85. PubMed ID: 11245702 [Abstract] [Full Text] [Related]
8. Allosteric modulation of the effect of escitalopram, paroxetine and fluoxetine: in-vitro and in-vivo studies. Mansari ME, Wiborg O, Mnie-Filali O, Benturquia N, Sánchez C, Haddjeri N. Int J Neuropsychopharmacol; 2007 Feb 15; 10(1):31-40. PubMed ID: 16448580 [Abstract] [Full Text] [Related]
9. Activation of postsynaptic 5-HT(1A) receptors by fluoxetine despite the loss of firing-dependent serotonergic input: electrophysiological and neurochemical studies. Sprouse J, Braselton J, Reynolds L, Clarke T, Rollema H. Synapse; 2001 Jul 15; 41(1):49-57. PubMed ID: 11354013 [Abstract] [Full Text] [Related]
13. CB1 knockout mice display impaired functionality of 5-HT1A and 5-HT2A/C receptors. Mato S, Aso E, Castro E, Martín M, Valverde O, Maldonado R, Pazos A. J Neurochem; 2007 Dec 15; 103(5):2111-20. PubMed ID: 17944876 [Abstract] [Full Text] [Related]
15. In vivo control of 5-hydroxytryptamine release by terminal autoreceptors in rat brain areas differentially innervated by the dorsal and median raphe nuclei. Hervás I, Bel N, Fernández AG, Palacios JM, Artigas F. Naunyn Schmiedebergs Arch Pharmacol; 1998 Sep 15; 358(3):315-22. PubMed ID: 9774218 [Abstract] [Full Text] [Related]
16. Brain-derived neurotrophic factor-deficient mice exhibit a hippocampal hyperserotonergic phenotype. Guiard BP, David DJ, Deltheil T, Chenu F, Le Maître E, Renoir T, Leroux-Nicollet I, Sokoloff P, Lanfumey L, Hamon M, Andrews AM, Hen R, Gardier AM. Int J Neuropsychopharmacol; 2008 Feb 15; 11(1):79-92. PubMed ID: 17559709 [Abstract] [Full Text] [Related]
18. Differential effects of 5-HT1A receptor deletion upon basal and fluoxetine-evoked 5-HT concentrations as revealed by in vivo microdialysis. He M, Sibille E, Benjamin D, Toth M, Shippenberg T. Brain Res; 2001 May 25; 902(1):11-7. PubMed ID: 11376590 [Abstract] [Full Text] [Related]
19. The 5-HT1A receptor antagonist (S)-UH-301 augments the increase in extracellular concentrations of 5-HT in the frontal cortex produced by both acute and chronic treatment with citalopram. Arborelius L, Nomikos GG, Hertel P, Salmi P, Grillner P, Höök BB, Hacksell U, Svensson TH. Naunyn Schmiedebergs Arch Pharmacol; 1996 May 25; 353(6):630-40. PubMed ID: 8738296 [Abstract] [Full Text] [Related]